Trialbee tar in 20 miljoner

Medicinteknikbolaget Trialbee tar in 20 miljoner kronor och värvar en ny chef till huvudkontoret i Malmö. Den största delen av kapitalet kommer från majoritetsägarna Industrifonden och Briban Invest, och ska användas för fortsatt utveckling och utlandsexpansion.

Trialbees marknadschef Robert Molander, som utgår från bolagets kontor i Research Triangle Park i North Carolina, ser kapitaltillskottet som en signal om att bolaget är på rätt väg i sin strävan att bli en viktig samarbetspartner för läkemedelsindustrin vid klinisk produktutveckling.

Robert Molander

– Det finns en stark tilltro till vår strategi och förmåga att attrahera kunder med global spännvidd, inte minst genom vårt nya samarbete med två av branschens största innovativa läkemedelsbolag, säger Robert Molander till Rapidus.

Vilka bolag det rör sig om vill han inte avslöja eftersom de själva ännu inte har gått ut med informationen. Som ett led i uppskalningen har Trialbee rekryterat en finans- och HR-chef, tillika vice vd, till kontoret i Malmö: Carlos Rodriguez. Han har erfarenhet från bland annat läkemedelsbolaget Amgen och kontraktsforskningsbolaget Trial Form Support – vars grundare Daniel Spasic är delägare i Trialbee. Malmöbolaget är också i slutfasen av att anställa en teknisk chef.

Trialbees IT-plattformar har utformats för att öka träffsäkerheten vid rekrytering av patienter och minska risken för avhopp från kliniska prövningar. Just patientavhopp är en springande punkt, uppger vd Lollo Eriksson, eftersom den statistiska signifikansen kan gå förlorad vid
många avhopp.

Lollo Eriksson

– Kliniska prövningar är både kostsamma och tidskrävande, så läkemedelsbolagen är angelägna om att patientrekryteringen är effektiv. De strävar också efter att maximera patenttiden. En försenad produktlansering kan innebära förlorade intäkter på upp till 50 miljoner dollar för ett enda läkemedel, säger han.

Trialbee sysselsätter drygt 30 personer som arbetar från huvudkontoret i Malmö eller från filialen i USA. Bolaget grundades 2010 av före detta Sony Eriksson-anställda Tobias Folkesson och Jonas Billing. Mellan 2016 och 2017 minskade bolagets nettoomsättning från cirka elva miljoner kronor till fyra miljoner, men målet att omsätta 500 miljoner kronor år 2022 står fast.

 

Jessika Nord
Denna artikel är ursprungligen publicerad i Rapidus nyhetsbrev och återpubliceras med tillstånd av Rapidus. Läs mer här

Trialbee Attracts Mr. Carlos Rodriguez As Head of Finance and HR

Trialbee, a world leading technology provider in patient matching and engagement, continues its talent growth by the recruitment of Mr. Carlos Rodriguez, a life science executive of 20 years in biotech, pharma and pharma services. Carlos has decided to join Trialbee’s leadership team as Head of Finance and HR.

Trialbee Continues to Contribute to Innovation in Diabetes

Trialbee is pleased to announce a new active partnership with the Diabetes Alliance Sweden. Trialbee´s active participation will hopefully act as a catalyst in the formation of new collaborations, securing that important innovations become available to diabetics in Sweden and globally. 

Trialbee Signs Two Top Ten Pharmaceutical Companies for its Patient-Matching and Engagement Platforms

 Trialbee announces two commercial milestones with two of the top 10 pharma companies. Trialbee has been selected to accelerate the clinical development of new drugs through its patient recruitment platform. The two partnerships also include deployment of Trialbee’s engagement application to ensure patient retention and study procedure compliance.

SCOPE Summit 2019

Meet us in Orlando, Florida during SCOPE Summit 2019, on Feb 18-21 where we will share our latest solutions and insights. Please contact Alicia Foley or Joe Buser to book a meeting.

Read more about SCOPE here.

Outsourcing-Pharma: Trialbee joins in on digital clinical solutions with patient-focused app

Trialbee, the digital patient recruitment and engagement company, has released its new digital solutions to build long-term relationships with clients, sponsors, and CROs. In this article, Maggie Lynch, Correspondent, Outsourcing-Pharma, chatted with Lollo Erikkson, CEO, Trialbee, to discuss how Trialbee’s Digital Patient Recruitment Solutions can improve patient motivation and data quality, as well as increase patient retention through digital engagement.

Read the full article here.

FierceBiotech: Recruitment specialist Trialbee unveils new patient recruitment and clinical trial platform

Recruitment specialist Trialbee released a new digital patient engagement solution designed to help increase patient retention, protocol compliance and treatment adherence by using customized messaging and support.

“Keeping study patients enrolled and actively engaged in a trial impacts data quality and boosts the statistical power of a study—enabling improved ability to detect differences between treatment groups and speed the process to market,” Hanne Van de Beek, the company’s customer project manager, said in a statement.

Read the full article from FierceBiotech  here.

Trialbee launches Digital Patient Engagement Solutions that enable patient-centric clinical trials

Sponsors, CROs and investigator sites benefit from working together with Trialbee to drive high-quality data and increase statistical power

 MALMÖ, SWEDEN — DECEMBER 04, 2018 — Trialbee, a global provider of best-in-class digital patient recruitment and engagement solutions for clinical research, announces the official release of its digital patient engagement solutions. With Trialbee, sponsors, CROs and investigator sites can increase patient retention, protocol compliance and adherence to treatment plans through customized messaging and support.Trialbee’s digital patient engagement solutions allow sponsors, CROs and sites to improve protocol adherence and reduce data variability, leading to fewer drop-outs and better patient retention. Improving patient retention leads to a more complete set of data points and higher quality data, boosting statistical power.

“Our integrated solutions improve our clients’ opportunities for success with marketing approval and go-to-market timeline,” said Hanne Van de Beek, customer project manager, Trialbee, and trained nurse with many years of experience in clinical drug development. “Keeping study patients enrolled and actively engaged in a trial impacts data quality and boosts the statistical power of a study – enabling improved ability to detect differences between treatment groups and speed the process to market.”

Trialbee puts clinical trials in the hands of patients by integrating studies into their daily lives through a bring-your-own-device (BYOD) application. The app is iOS and Android compatible and includes patient-centric features that can be customized to empower patients with the necessary tools and information, and optimize engagement throughout the entire trial.

The integrated site personnel administration tool and “Participant Manager” simplify site workflow and decrease work burden on research sites. Built-in interactive response technology (IRT) connects patients to sites, driving better adherence to treatment, higher quality data, and improved patient retention.

“We work in close partnership with our clients to put real-time patient data at their fingertips,” said Lollo Eriksson, CEO, Trialbee. “These are long-term relationships in which we customize patient-centric solutions that allow clients to keep patients actively engaged and track and analyze patient flow throughout the entire clinical trial lifecycle.”

About Trialbee

Trialbee empowers patients worldwide with clinical trials as a care option through best-in-class digital patient recruitment and engagement. Founded in 2010 in Sweden, Trialbee has continuously innovated patient-centric solutions for global clinical trials. Trialbee – Dedicated to patients; driven by science; and powered by data. For more information, visit trialbee.com and contact us at [email protected].

Clinical Trials Patient Experience Summit

Join Trialbee in San Francisco, September 12-13, for the Clinical Trials Patient Experience Summit! Set up a meeting with our experienced team members to discuss how to empower patients with clinical trials as a care option through best-in-class digital patient recruitment and retention.

Read more about the Clinical Trials Patient Experience Summit.

7th Annual Patient Recruitment and Retention America Summit

Join Trialbee in Boston, 23-25 October, for the 7th Annual Patient Recruitment and Retention America Summit! Visit booth 6 and discuss how to recruit targeted patients for your clinical trial and how to increase patient retention, compliance, and adherence to treatment plans with our engagement app. In addition, you won’t want to miss Robert Molander, Senior Vice President Marketing, Trialbee, present Clinical Trials as a Care Option at 15:30 on 24 October, where he will discuss making clinical trials more accessible through targeted outreach and smart patient matching.

Read more about the Patient Recruitment and Retention America Summit.

Cookie Preferences

Cloudflare

The Cloudflare cookie is used to identify individual clients behind a shared IP address and apply security settings on a per-client basis.

PHPSESSID,wp-settings-time-1

Google Analytics

Used by Google AdWords to re-engage visitors that are likely to enrol based on the visitor's online behaviour across websites.

_ga,_gid,_gat_UA,_utmc,UULE,CONSENT,1P_JAR,DV

Trialbeehealth

Wordpress built-in cookies to keep user settings after page transitions.

PHPSESSID,wp-settings-time-1

Close your account?

Your account will be closed and all data will be permanently deleted and cannot be recovered. Are you sure?